MPM BioImpact LLC - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
MPM BioImpact LLC ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$2,045,000
-63.6%
97,322
-66.3%
0.48%
-69.0%
Q2 2022$5,615,000
-11.6%
288,5310.0%1.56%
-8.5%
Q1 2022$6,353,000
+33.3%
288,531
-3.5%
1.70%
+96.2%
Q4 2021$4,767,000
-22.4%
298,852
-3.1%
0.87%
-8.8%
Q3 2021$6,146,000308,5320.95%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,921,118$38,077,0005.86%
FRAZIER MANAGEMENT LLC 3,566,912$70,696,0005.67%
Burrage Capital Management LLC 205,866$4,080,0003.31%
Novo Holdings A/S 2,445,147$48,463,0002.00%
NEA Management Company, LLC 4,187,801$83,002,0001.86%
Sio Capital Management, LLC 437,138$8,664,0001.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$68,357,0001.44%
Rock Springs Capital Management LP 1,502,800$29,785,0000.65%
Sofinnova Investments, Inc. 476,401$9,442,0000.57%
Boxer Capital, LLC 317,000$6,283,0000.21%
View complete list of MIRUM PHARMACEUTICALS INC shareholders